Download PDF
Dtsch Med Wochenschr 2018; 143(06): 397-405
DOI: 10.1055/s-0043-111728
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Thyreotoxische Krise und Myxödemkoma

Thyroid Storm and Myxedema Coma
Malte Milkau
,
Friedhelm Sayk
Further Information

Publication History

Publication Date:
15 March 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Thyroid storm and myxedema coma are the most severe clinical forms of thyroid dysfunction. While both hyper- and hypothyroidsm are common diseases, thyroid storm and myxedema coma are rare. Due to their unspecific signs and symptoms they are often difficult to diagnose. Both disorders are medical emergencies, which still show a significant mortality. The following article summarizes diagnostic tools and treatment options for these disorders

Die thyreotoxische Krise und das Myxödemkoma stellen lebensbedrohliche Verlaufsformen der Hyper- bzw. Hypothyreose dar. Sie sind jedoch nicht nur Extremformen eines klinischen Spektrums, sondern auch Entitäten mit eigenen Charakteristika. Die Abgrenzung zu noch kompensierten Formen ist unscharf und selbst bei suffizienter multimodaler Therapie gehen sie mit einer relevanten Mortalität einher.

Schlüsselwörter

Thyreotoxische Krise - Myxödemkoma - Funktionsstörungen der Schilddrüse

Key words

thyroid storm - myxedema - myxedema coma
 

  • Literatur

  • 1 Zender S, Dölle M, Terkamp C. et al. Intensivmedizinische Behandlung der thyreotoxischen Krise. Intensivmed.up2date 2016; 12: 291-302
    PubMedGoogle Scholar
  • 2 Dietrich JW. Thyreotoxische Krise. Medizinische Klinik, Intensivmedizin und Notfallmedizin 2012; 107: 448-453
    CrossrefPubMedGoogle Scholar
  • 3 Akamizu T, Satoh T, Isozaki O. et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 2012; 22: 661-679
    CrossrefPubMedGoogle Scholar
  • 4 Satoh T, Isozaki O, Suzuki A. et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition). Endocrine journal 2016; 63: 1025-1064
    CrossrefPubMedGoogle Scholar
  • 5 Angell TE, Lechner MG, Nguyen CT. et al. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endocrinol Metab 2015; 100: 451-459
    CrossrefPubMedGoogle Scholar
  • 6 Ross DS, Burch HB, Cooper DS. et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016; 26: 1343-1421
    CrossrefPubMedGoogle Scholar
  • 7 Wilson S, Parle JV, Roberts LM. et al. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J Clin Endocrinol Metab 2006; 91: 4809-4816
    CrossrefPubMedGoogle Scholar
  • 8 Ono Y, Ono S, Yasunaga H. et al. Clinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan. Journal of epidemiology 2017; 27: 117-122
    CrossrefPubMedGoogle Scholar
  • 9 Dutta P, Bhansali A, Masoodi SR. et al. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care 2008; 12: R1
    PubMedGoogle Scholar
  • 10 Chiong YV, Bammerlin E, Mariash CN. Development of an objective tool for the diagnosis of myxedema coma. Transl Res 2015; 166: 233-243
    CrossrefPubMedGoogle Scholar
  • 11 Ono Y, Ono S, Ysunaga H. et al. Clinical characteristics and outcome of myxedema coma: analysis of a ational inpatient database in Japan. Journal of Endocrinology 2017; 27: 117-122
    PubMedGoogle Scholar
  • 12 Popoveniuc GChandra T, Sud A. et al. A diagnostic scoring system for myxedema coma. Endocr Pract 2015; 20: 808-817
    PubMedGoogle Scholar